There are reports showing the occurrence of rheumatic diseases after DPP-4i use in patients with diabetes [45,46,47,48] or an association of DPP-4 expression or its enzymatic activity with the disease activity of RA [44]. Here, DPP4 is linked to rheumatoid arthritis.